OSEL INC has a total of 34 patent applications. Its first patent ever was published in 1998. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are PENN MARC S, MARSHALL BARRY J and GLOBEIMMUNE INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 11 | |
#2 | WIPO (World Intellectual Property Organization) | 7 | |
#3 | EPO (European Patent Office) | 5 | |
#4 | China | 4 | |
#5 | Australia | 3 | |
#6 | Canada | 3 | |
#7 | Japan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology | |
#4 | Measurement | |
#5 | Medical technology | |
#6 | Machines |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Microorganisms | |
#4 | Peptides | |
#5 | Climate change adaptation technologies | |
#6 | Measuring microorganism processes | |
#7 | Analysing materials | |
#8 | Spraying devices | |
#9 | Syringes | |
#10 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Parks Thomas P | 13 |
#2 | Xu Qiang | 10 |
#3 | Lewicki John A | 8 |
#4 | Chang Chia-Hwa | 8 |
#5 | Simpson David A | 7 |
#6 | Lee Peter P | 6 |
#7 | Marcobal Angela | 6 |
#8 | Liu Xiaowen | 5 |
#9 | Humaidan Peter | 5 |
#10 | Uldbjerg Niels | 5 |
Publication | Filing date | Title |
---|---|---|
WO2020047203A2 | Bacteriocins to improve vaginal colonization of hydrogen peroxide producing lactobacillus for female reproductive health | |
EP3648778A1 | High potency stable formulations of vaginal lactobacillus | |
CN110831610A | Use of vaginal lactobacillus for improving success rate of in vitro fertilization | |
WO2009079607A1 | Applicator for applying powder formulations and uses thereof | |
US2006194226A1 | Modified cyanovirin-n polypeptide | |
WO2005012491A2 | Surface expression of biologically active proteins in bacteria | |
AU2003276822A8 | Lactobacilli expressing biologically active polypeptides and uses thereof | |
CN1355690A | Method for improving half-life of soluble viral-specific ligands on mucosal membranes | |
EP1011721A1 | Vaginal lactobacillus medicant |